249 related articles for article (PubMed ID: 10759189)
1. Nuclear localization and mutation of beta-catenin in medulloblastomas.
Eberhart CG; Tihan T; Burger PC
J Neuropathol Exp Neurol; 2000 Apr; 59(4):333-7. PubMed ID: 10759189
[TBL] [Abstract][Full Text] [Related]
2. Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors.
Koch A; Waha A; Tonn JC; Sörensen N; Berthold F; Wolter M; Reifenberger J; Hartmann W; Friedl W; Reifenberger G; Wiestler OD; Pietsch T
Int J Cancer; 2001 Aug; 93(3):445-9. PubMed ID: 11433413
[TBL] [Abstract][Full Text] [Related]
3. Control of beta-catenin/Tcf-directed transcription in medulloblastoma.
Raffel C
Acta Paediatr Suppl; 2004 May; 93(445):12-6; discussion 16-7. PubMed ID: 15176713
[TBL] [Abstract][Full Text] [Related]
4. Role of Wnt pathway in medulloblastoma oncogenesis.
Yokota N; Nishizawa S; Ohta S; Date H; Sugimura H; Namba H; Maekawa M
Int J Cancer; 2002 Sep; 101(2):198-201. PubMed ID: 12209999
[TBL] [Abstract][Full Text] [Related]
5. Sporadic medulloblastomas contain oncogenic beta-catenin mutations.
Zurawel RH; Chiappa SA; Allen C; Raffel C
Cancer Res; 1998 Mar; 58(5):896-9. PubMed ID: 9500446
[TBL] [Abstract][Full Text] [Related]
6. beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee.
Ellison DW; Onilude OE; Lindsey JC; Lusher ME; Weston CL; Taylor RE; Pearson AD; Clifford SC;
J Clin Oncol; 2005 Nov; 23(31):7951-7. PubMed ID: 16258095
[TBL] [Abstract][Full Text] [Related]
7. Mutations of the Wnt antagonist AXIN2 (Conductin) result in TCF-dependent transcription in medulloblastomas.
Koch A; Hrychyk A; Hartmann W; Waha A; Mikeska T; Waha A; Schüller U; Sörensen N; Berthold F; Goodyer CG; Wiestler OD; Birchmeier W; Behrens J; Pietsch T
Int J Cancer; 2007 Jul; 121(2):284-91. PubMed ID: 17373666
[TBL] [Abstract][Full Text] [Related]
8. Aberrant nuclear localization and gene mutation of beta-catenin in low-grade adenocarcinoma of fetal lung type: up-regulation of the Wnt signaling pathway may be a common denominator for the development of tumors that form morules.
Nakatani Y; Masudo K; Miyagi Y; Inayama Y; Kawano N; Tanaka Y; Kato K; Ito T; Kitamura H; Nagashima Y; Yamanaka S; Nakamura N; Sano J; Ogawa N; Ishiwa N; Notohara K; Resl M; Mark EJ
Mod Pathol; 2002 Jun; 15(6):617-24. PubMed ID: 12065775
[TBL] [Abstract][Full Text] [Related]
9. beta-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer.
Clements WM; Wang J; Sarnaik A; Kim OJ; MacDonald J; Fenoglio-Preiser C; Groden J; Lowy AM
Cancer Res; 2002 Jun; 62(12):3503-6. PubMed ID: 12067995
[TBL] [Abstract][Full Text] [Related]
10. Hepatic adenomas: analysis of sex steroid receptor status and the Wnt signaling pathway.
Torbenson M; Lee JH; Choti M; Gage W; Abraham SC; Montgomery E; Boitnott J; Wu TT
Mod Pathol; 2002 Mar; 15(3):189-96. PubMed ID: 11904335
[TBL] [Abstract][Full Text] [Related]
11. Failure of a medulloblastoma-derived mutant of SUFU to suppress WNT signaling.
Taylor MD; Zhang X; Liu L; Hui CC; Mainprize TG; Scherer SW; Wainwright B; Hogg D; Rutka JT
Oncogene; 2004 Jun; 23(26):4577-83. PubMed ID: 15077159
[TBL] [Abstract][Full Text] [Related]
12. Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas.
Dahmen RP; Koch A; Denkhaus D; Tonn JC; Sörensen N; Berthold F; Behrens J; Birchmeier W; Wiestler OD; Pietsch T
Cancer Res; 2001 Oct; 61(19):7039-43. PubMed ID: 11585731
[TBL] [Abstract][Full Text] [Related]
13. An investigation of WNT pathway activation and association with survival in central nervous system primitive neuroectodermal tumours (CNS PNET).
Rogers HA; Miller S; Lowe J; Brundler MA; Coyle B; Grundy RG
Br J Cancer; 2009 Apr; 100(8):1292-302. PubMed ID: 19293793
[TBL] [Abstract][Full Text] [Related]
14. Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia.
Eberhart CG; Kratz J; Wang Y; Summers K; Stearns D; Cohen K; Dang CV; Burger PC
J Neuropathol Exp Neurol; 2004 May; 63(5):441-9. PubMed ID: 15198123
[TBL] [Abstract][Full Text] [Related]
15. Accumulation of beta-catenin protein and mutations in exon 3 of beta-catenin gene in gastrointestinal carcinoid tumor.
Fujimori M; Ikeda S; Shimizu Y; Okajima M; Asahara T
Cancer Res; 2001 Sep; 61(18):6656-9. PubMed ID: 11559529
[TBL] [Abstract][Full Text] [Related]
16. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.
Kolligs FT; Kolligs B; Hajra KM; Hu G; Tani M; Cho KR; Fearon ER
Genes Dev; 2000 Jun; 14(11):1319-31. PubMed ID: 10837025
[TBL] [Abstract][Full Text] [Related]
17. Cytoplasmic and nuclear accumulation of beta-catenin is rarely caused by CTNNB1 exon 3 mutations in cutaneous malignant melanoma.
Omholt K; Platz A; Ringborg U; Hansson J
Int J Cancer; 2001 Jun; 92(6):839-42. PubMed ID: 11351304
[TBL] [Abstract][Full Text] [Related]
18. APC mutations in sporadic medulloblastomas.
Huang H; Mahler-Araujo BM; Sankila A; Chimelli L; Yonekawa Y; Kleihues P; Ohgaki H
Am J Pathol; 2000 Feb; 156(2):433-7. PubMed ID: 10666372
[TBL] [Abstract][Full Text] [Related]
19. Intracellular distribution of beta-catenin in human medulloblastoma cell lines with different degree of neuronal differentiation.
Salaroli R; Russo A; Ceccarelli C; Mina GD; Arcella A; Martinelli GN; Giangaspero F; Capranico G; Cenacchi G
Ultrastruct Pathol; 2007; 31(1):33-44. PubMed ID: 17455096
[TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of the beta-catenin gene in gastric carcinomas.
Sasaki Y; Morimoto I; Kusano M; Hosokawa M; Itoh F; Yanagihara K; Imai K; Tokino T
Tumour Biol; 2001; 22(2):123-30. PubMed ID: 11125285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]